Status:
UNKNOWN
TICS: Transcranial Magnetic Stimulation for Intervening in Children With Tourette's Syndrome (CIHR)
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Tic Disorders
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
Tourette's Syndrome (TS) is characterized by repetitive movements and vocalizations called tics. Due to the suffering caused by TS, children and adolescents often require treatment for their tics. The...
Detailed Description
Tourette's Syndrome (TS) is characterized by repetitive movements and vocalizations called tics. Due to the suffering caused by TS, children and adolescents often require treatment for their tics. Tic...
Eligibility Criteria
Inclusion
- Diagnosis of Tourette's syndrome
- IQ greater than 80
- English fluency (to enable assent and consent).
Exclusion
- Diagnosis of mania or schizophrenia
- Impediments to TMS or MRI.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03844919
Start Date
September 1 2019
End Date
November 1 2022
Last Update
November 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alberta Children's Hospital
Calgary, Alberta, Canada, T3B 6A8